the importance of putting into place suitable financing mechanisms and a transparent and internationally verifiable compliance regime

If they wish to fight commonsense consumer protections, that's a fight I'm more than willing to have.

Financial reform is critical: to put in place rules that will allow the Nation's markets to promote innovation while discouraging abuse.

I will make sure those insurance companies can never do that again.

Americans benefit from strong and effective food and product safety standards.

Close these corporate loopholes the lobbyists put in.

The Act is designed to expedite the animal drug development process, while continuing to ensure the safety and effectiveness of animal drugs.

Under this new rule, for the first time, health plans would be required to make coverage decisions quickly— within 72 hours for urgent requests—and to provide consumers with meaningful information on their rights and benefits.

Because charter schools are exempt from many regulations governing traditional public schools, they have more freedom to develop innovative educational programs.

We have to adjust our rules for this new age, to protect the zone of privacy and give consumers choice.

We would not agree with those who attempted to weaken the CRA obligations of banks and thrifts in this process.

I also am disturbed that the conference report includes new language that is aimed at restricting efforts to reduce smog by delaying EPA action on several States' clean air petitions.

While the majority of imported food is safe, problems do exist.

Today I want to talk about what we must do to ensure that the food we serve at those gatherings is as safe as we can possibly make it.

We must do all that we can to protect Americans from unsafe food.

With this new rule, and with these three simple attachments, we can save lives and prevent up to 3,000 injuries a year.

Confirming the FDA's authority over tobacco products is necessary to help stop young people from smoking before they start.

The legitimate commercial activities and interests of chemical, biotechnology, and pharmaceutical firms in the United States are not being significantly harmed by the limitations of the Convention on access to, and production of, those chemicals and toxins listed in Schedule 1 of the Annex on Chemicals.